Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 2 |
Microsoft
MSFT
|
+$671M |
| 3 |
Spotify
SPOT
|
+$586M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$406M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.7B |
| 2 |
Amazon
AMZN
|
+$1.48B |
| 3 |
Merck
MRK
|
+$884M |
| 4 |
Broadcom
AVGO
|
+$823M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$698M |
Sector Composition
| 1 | Technology | 15.81% |
| 2 | Healthcare | 13.31% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 11.5% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
SK Telecom
SKM
$8.43B
| $4.56M | ﹤0.01% |
191,760
+32,894
| +21% | +$782K |
|
1927
Copa Holdings
CPA
$4.78B
| $4.55M | ﹤0.01% |
48,509
-433,670
| -90% | -$40.7M |
|
1928
Acumen Pharmaceuticals
ABOS
$74.5M
| $4.55M | ﹤0.01% |
1,834,753
-119,332
| -6% | -$296K |
|
1929
Heritage Insurance Holdings
HRTG
$759M
| $4.54M | ﹤0.01% |
370,732
+178,443
| +93% | +$2.18M |
|
1930
LeMaitre Vascular
LMAT
$2.09B
| $4.54M | ﹤0.01% |
48,831
-27,374
| -36% | -$2.54M |
|
1931
Inhibrx
INBX
$385M
| $4.53M | ﹤0.01% |
289,361
-13,835
| -5% | -$217K |
|
1932
Cannae Holdings
CNNE
$1.14B
| $4.52M | ﹤0.01% |
237,257
+188,240
| +384% | +$3.59M |
|
1933
TriMas Corp
TRS
$1.6B
| $4.52M | ﹤0.01% |
176,885
-40,497
| -19% | -$1.03M |
|
|
HONDU
1934
HCM II Acquisition Corp. Unit
HONDU
| $4.5M | ﹤0.01% |
+450,000
| New | +$4.5M |
|
|
VCICU
1935
Vine Hill Capital Investment Corp. Unit
VCICU
| $4.5M | ﹤0.01% |
+450,000
| New | +$4.5M |
|
1936
National Vision
EYE
$1.9B
| $4.49M | ﹤0.01% |
411,947
-183,788
| -31% | -$2.01M |
|
1937
Absci
ABSI
$404M
| $4.49M | ﹤0.01% |
1,174,829
+363,056
| +45% | +$1.39M |
|
|
SOHU
1938
Sohu.com
SOHU
$471M
| $4.48M | ﹤0.01% |
284,402
-84,043
| -23% | -$1.32M |
|
1939
Q32 Bio
QTTB
$22.9M
| $4.48M | ﹤0.01% |
+100,343
| New | +$4.48M |
|
1940
RLX Technology
RLX
$3.12B
| $4.47M | ﹤0.01% |
2,468,860
+1,217,821
| +97% | +$2.2M |
|
1941
Genpact
G
$7.2B
| $4.46M | ﹤0.01% |
113,767
+37,082
| +48% | +$1.45M |
|
1942
Pitney Bowes
PBI
$1.96B
| $4.46M | ﹤0.01% |
625,205
+141,524
| +29% | +$1.01M |
|
|
AAMI
1943
Acadian Asset Management Inc.
AAMI
$1.74B
| $4.44M | ﹤0.01% |
174,934
-61,632
| -26% | -$1.57M |
|
1944
Columbus McKinnon
CMCO
$426M
| $4.43M | ﹤0.01% |
122,952
-76,774
| -38% | -$2.76M |
|
1945
Sandstorm Gold
SAND
$3.47B
| $4.41M | ﹤0.01% |
735,483
+139,976
| +24% | +$840K |
|
1946
Amicus Therapeutics
FOLD
$2.47B
| $4.41M | ﹤0.01% |
412,565
-1,481,611
| -78% | -$15.8M |
|
|
LGTY
1947
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $4.4M | ﹤0.01% |
393,058
+172,497
| +78% | +$1.93M |
|
1948
Henry Schein
HSIC
$8.29B
| $4.39M | ﹤0.01% |
60,178
-86,699
| -59% | -$6.32M |
|
1949
Vanguard Real Estate ETF
VNQ
$34.5B
| $4.38M | ﹤0.01% |
+45,000
| New | +$4.38M |
|
1950
Procept Biorobotics
PRCT
$2.2B
| $4.38M | ﹤0.01% |
54,606
-38,086
| -41% | -$3.05M |
|